You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 18, 2024

SPECTAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Spectazole patents expire, and when can generic versions of Spectazole launch?

Spectazole is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in SPECTAZOLE is econazole nitrate. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Spectazole

A generic version of SPECTAZOLE was approved as econazole nitrate by TARO on November 26th, 2002.

  Try a Trial

US Patents and Regulatory Information for SPECTAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SPECTAZOLE

See the table below for patents covering SPECTAZOLE around the world.

Country Patent Number Title Estimated Expiration
Netherlands 169071 ⤷  Try a Trial
Germany 2063857 ⤷  Try a Trial
Sweden 394432 IMIDAZOLDERIVAT TILL ANVENDNING FOR BEKEMPNING AV SVAMPAR ⤷  Try a Trial
Germany 1940388 1-(BETA-ARYL) AETHYLIMIDAZOLDERIVATE, IHRE HERSTELLUNG UND DIESE ENTHALTENDE FUNGIZIDE UND BAKTERIZIDE MITTEL ⤷  Try a Trial
Israel 32840 1-(BETA-ARYL-ETHYL)-IMIDAZOLE ETHERS AND AMINES ⤷  Try a Trial
Spain 390807 ⤷  Try a Trial
Denmark 140213 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.